skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Table of Contents

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Appendix A: Key to Acronyms

General Terms

(Last updated: July 14, 2016; last reviewed: July 14, 2016)

General Terms
Abbreviation Full Name
17-BMP beclomethasone 17-monopropionate
Al
aluminum 
ALT alanine aminotransferase
ART antiretroviral therapy
ARV antiretroviral 
AST aspartate aminotransferase
AUC area under the curve
AWP average wholesale price
BID
twice daily
BMD 
bone mineral density
Ca
calcium 
CaCO3  
calcium carbonate
cap
capsule 
CCB calcium channel blockers 
CD4 
CD4 T lymphocyte 
CKD chronic kidney disease
Cl chloride
Cmax
maximum plasma concentration
Cmin 
minimum plasma concentration
CNS   central nervous system
CPK 
creatine phosphokinase 
CrCl 
creatinine clearance 
CVD
cardiovascular disease
CYP 
cytochrome P 
DAAs direct-acting antivirals
DHA dihydroartemisinin
DMPA 
depot medroxyprogesterone acetate
EC 
enteric coated 
ECG 
electrocardiogram
eGFR estimated glomerular filtration rate
EI 
entry inhibitor
FDA Food and Drug Administration 
Fe iron
GAZT azidothymidine glucuronide
GI
gastrointestinal 
HBsAb hepatitis B surface antibody
HBsAg hepatits B surface antigen
HBV 
hepatitis B virus 
HCO3 bicarbonate
HCV 
hepatitis C virus 
HD hemodialysis
HDL 
high-density lipoprotein 
HLA 
human leukocyte antigen 
HMG-CoA
hydroxy-methylglutaryl-coenzyme A
HSR 
hypersensitivity reaction
INR
international normalized ratio
INSTI 
integrase strand transfer inhibitor 
K potassium
LDL 
low-density lipoprotein
MAC
Mycobacterium avium complex
MATE 
multidrug and toxin extrusion transporter 
Mg magnesium 
MI myocardial infarction
MPA medroxyprogesterone acetate
N/A
Not Applicable
Na sodium
NNRTI 
non-nucleoside reverse transcriptase inhibitor
NRTI 
nucleoside reverse transcriptase inhibitor
OCT2
organic cation transporter 2 
OH-itraconazole
active metabolite of itraconazole
PAH pulmonary arterial hypertension 
PCP Pneumocystis jiroveci pneumonia
PDE5 phosphodiesterase type 5 
PI protease inhibitor
PPI proton pump inhibitor 
PK pharmacokinetic
PO orally
PPI  Proton pump inhibitor
q(n)d  every (n) days
q(n)h every (n) hours
QTc QT corrected for heart rate 
SCr serum creatinine
SJS Stevens-Johnson syndrome
SSRI selective serotonin reuptake inhibitor
STR single-tablet regimen
TB tuberculosis 
TCA tricyclic anti-depressant 
TEN toxic epidermal necrosis
TG triglyceride 
TID three times a day 
UGT1A1
uridine diphosphate glucuronosyltransferase
VPA valproic acid
WHO World Health Organization
XR extended release
Zn Zinc

Back to Top